Neurogene NGNE
NASDAQ NGNE
$25.28 -0.72 (-2.77%)
At close: Nov 10, 2026 · 4:00 PM EST

Neurogene (NGNE) Revenue (2015 - 2024)

Updated

Neurogene (NGNE) posted Revenue of $925,000 for FY2024.

Analysis

Neurogene (NGNE) Revenue (2015 - 2024) Analysis & Trends

  • Annual Revenue shows a five-year compound annual growth rate of -75.3% (FY2019 to FY2024).
  • The FY2024 figure stands as the highest annual Revenue since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 25.40 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 17.40 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 15.38 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 8.30 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 16.58 Bn
10 Neurogene 577.56 Mn -425.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 925,000.00
Mar 31, 2023 945,000.00
Dec 31, 2022 816,000.00
Sep 30, 2022 559,000.00
Jun 30, 2022 194,000.00
Mar 31, 2022 13,000.00
Dec 31, 2021 5,000.00
Sep 30, 2021 6,000.00
Sep 30, 2019 1.00 Bn
Jun 30, 2018 25.00 Mn
Sep 30, 2016 142,000.00
Jun 30, 2016 128,000.00
Mar 31, 2016 121,000.00
Sep 30, 2015 9,000.00
Jun 30, 2015 12,000.00
Mar 31, 2015 15,000.00
API Access

Neurogene Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=NGNE&period=max&api_key=YOUR_API_KEY